Wellfully Ltd WFL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.00
- Day Range
- A$0.00–0.00
- 52-Week Range
- A$0.00–0.05
- Bid/Ask
- A$0.00 / A$0.00
- Market Cap
- A$1.48 Mil
- Volume/Avg
- 725,177 / 2.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.74
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Wellfully Ltd is engaged in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates in segments namely the development of the dermaportation drug delivery technology and Devices segments. Geographically, it derives a majority of its revenue from Europe and also has a presence in Japan. It serves the Pharmaceutical; Cosmetics Skincare and Consumer Healthcare industries.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 1
- Website
- https://wellfully.net
Valuation
|
Metric
|
WFL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.74 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
WFL
|
|---|---|
Quick Ratio | 0.30 |
Current Ratio | 0.81 |
Interest Coverage | — |
Quick Ratio
WFL
Profitability
|
Metric
|
WFL
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
WFL
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Skycvjpyz | Pwqs | $208.9 Bil | |
DHR
| Danaher Corp | Bbwspwnwz | Snmzyrh | $177.3 Bil | |
IQV
| IQVIA Holdings Inc | Ttlbrpjv | Nkwgs | $41.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Chyhkfvzhg | Rsjqqwz | $39.7 Bil | |
A
| Agilent Technologies Inc | Fftdylvfr | Tyrtr | $39.4 Bil | |
MTD
| Mettler-Toledo International Inc | Gcgbcblzg | Bkvdtrt | $25.6 Bil | |
ICLR
| Icon PLC | Kyyjbsqbl | Bsmwcrf | $24.1 Bil | |
ILMN
| Illumina Inc | Wgyhymtm | Pmrppnf | $18.8 Bil | |
WAT
| Waters Corp | Ylhrtcxyr | Yjcct | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Ymclvbqwcc | Cngfdj | $16.8 Bil |